Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria

Journal: Nature

Published: 2020-04-22

DOI: 10.1038/s41586-020-2220-1

Affiliations: 19

Authors: 33

Go to article
Institutions Share
Lifespan Health System, United States of America (USA) 0.26
Department of Pathology and Laboratory Medicine, Brown University, United States of America (USA) 0.17
NIH NIAID Laboratory of Malaria Immunology and Vaccinology (LMIV), United States of America (USA) 0.12
Charles E. Schmidt College of Medicine, FAU, United States of America (USA) 0.09
Acuitas Therapeutics, Canada 0.06
Department of Medicine, Penn, United States of America (USA) 0.06
Department of Microbiology and Immunology, CU, United States of America (USA) 0.05
Division of Infectious Diseases, BCH, United States of America (USA) 0.03
Harvard Department of Pediatrics, United States of America (USA) 0.03
Centers for Disease Control and Prevention (CDC), United States of America (USA) 0.03
College of Urban Science, UOS, South Korea 0.02
Division of Infectious Diseases, CU, United States of America (USA) 0.02
Rhode Island Hospital, Brown University, United States of America (USA) 0.02
Yale Department of Microbial Pathogenesis, United States of America (USA) 0.02
Yale Department of Internal Medicine, United States of America (USA) 0.02
St Augustine’s Hospital, Tanzania 0.01
Center for Infectious Disease Research (CIDR), United States of America (USA) 0.01
Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER